Inke S.A: APIs manufacturing plant.
01 1INKE SA
02 1Dr.Reddy's Laboratories Limited
03 1Aurobindo Pharma Limited
04 1Emcure Pharmaceuticals Limited
05 1Glenmark Life Sciences Limited
06 1Hetero Drugs Limited
07 1Jubilant Pharmova Limited
08 1MYLAN LABORATORIES LIMITED
09 1Natco Pharma Limited
10 1Pliva Croatia Ltd
11 1SMS Pharmaceuticals Limited
12 1Tianish Laboratories Private Limited
01 3ZOLMITRIPTAN
02 8Zolmitriptan
03 1zolmitriptan
01 1Croatia
02 9India
03 1Spain
04 1U.S.A
Inke S.A: APIs manufacturing plant.
NDC Package Code : 64567-0016
Start Marketing Date : 2009-10-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-800
Start Marketing Date : 2012-03-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-801
Start Marketing Date : 2024-01-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14593-863
Start Marketing Date : 2023-12-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66039-845
Start Marketing Date : 2008-12-02
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0050
Start Marketing Date : 1997-11-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1145
Start Marketing Date : 2010-03-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63850-4322
Start Marketing Date : 2016-01-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 11722-012
Start Marketing Date : 2017-12-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-688
Start Marketing Date : 2015-01-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Zolmitriptan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zolmitriptan, including repackagers and relabelers. The FDA regulates Zolmitriptan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zolmitriptan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zolmitriptan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zolmitriptan supplier is an individual or a company that provides Zolmitriptan active pharmaceutical ingredient (API) or Zolmitriptan finished formulations upon request. The Zolmitriptan suppliers may include Zolmitriptan API manufacturers, exporters, distributors and traders.
click here to find a list of Zolmitriptan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zolmitriptan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zolmitriptan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zolmitriptan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zolmitriptan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zolmitriptan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zolmitriptan suppliers with NDC on PharmaCompass.
We have 12 companies offering Zolmitriptan
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
